Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of CKD-387 in Healthy Subjects
NCT04156685Phase 1Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Aug 2019
- Primary completion
- Aug 2019
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of D484 in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Chong Kun Dang Holdings. Started Aug 2019; status: completed.
02
Drugs
D484
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04156685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04156685.